Andreas Makris

Recommendations From an International Expert Panel on the Use of Neoadjuvant (Primary) Systemic Treatment of Operable Breast Cancer: An Update

Manfred Kaufmann, Gabriel N. Hortobágyi, Aron Goldhirsch et al. · Journal of Clinical Oncology · 2006 · 718 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +13

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer.

T.J. Powles, Tamas Hickish, Andreas Makris et al. · Journal of Clinical Oncology · 1995 · 352 citations

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

Andreas Makris, T.J. Powles, S. Ashley et al. · Annals of Oncology · 1998 · 317 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +9

Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

Sibylle Loibl, Frederik Marmé, Miguel Martín et al. · Journal of Clinical Oncology · 2021 · 310 citations

Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast Cancer

Mei-Lin W. Ah-See, Andreas Makris, N. Jane Taylor et al. · Clinical Cancer Research · 2008 · 262 citations